Ketamine Therapy for Chronic Pain in Fort Myers: What We Know and Who We Help

ketamine therapy for chronic pain near me in fort myers fl

The American Academy of Pain Medicine estimates that chronic pain affects more than 100 million Americans — more than heart disease, cancer, and diabetes combined — yet many of the most common pharmacological approaches offer only partial relief and carry significant risks with long-term use. For patients with conditions like complex regional pain syndrome, fibromyalgia, and neuropathic pain, the neuroscience of why pain persists has changed dramatically in the last decade, and treatment approaches are beginning to follow. At Dura Medical in Fort Myers, our team has developed clinical expertise in ketamine therapy for chronic pain, and we want patients across Southwest Florida to understand how this off-label application works and who is most likely to benefit.

How Ketamine Works for Chronic Pain

Ketamine was originally developed as an anesthetic agent and continues to be used in that capacity in surgical and emergency medicine settings. Its application to chronic pain is classified as off-label use — meaning it is not FDA-approved for this indication, but it is administered based on a growing body of clinical research that has accumulated over several decades. The distinction between off-label use and experimental use is important: off-label use of established medications is extremely common in medicine and is ethically appropriate when supported by clinical evidence and conducted with informed consent. Our team at Dura Medical takes the responsibility of off-label administration seriously, and every patient who receives ketamine at our facility undergoes a thorough evaluation that considers their full pain history, prior treatment attempts, and current medical status.

The reason ketamine is studied for chronic pain lies in its mechanism of action. Many chronic pain conditions — particularly those characterized by widespread, diffuse pain that has persisted beyond the expected healing timeline — involve a process called central sensitization. In central sensitization, the central nervous system becomes hyperactivated, amplifying pain signals far beyond what the peripheral injury or inflammation would explain. The NMDA receptors that ketamine blocks play a central role in this process. By interrupting the excitatory signaling that perpetuates central sensitization, ketamine can effectively “reset” an overactivated pain pathway in ways that conventional analgesics, which typically target peripheral mechanisms, are unable to achieve.

At Dura Medical, our team administers IV ketamine for chronic pain conditions including complex regional pain syndrome (CRPS), fibromyalgia, neuropathic pain, and migraine. CRPS in particular has been the subject of substantial research interest in the ketamine space — its hallmark feature of disproportionate, spreading pain that has long outrun its initial injury makes it a textbook example of central sensitization, and multiple studies have demonstrated meaningful pain reduction following ketamine infusion series in CRPS patients. We are careful to present these findings in context: ketamine therapy may help reduce pain intensity, improve functional capacity, and reduce reliance on other analgesics, but it is not a cure, and results vary by individual. To understand more about ketamine therapy for chronic pain treatment in Naples and Fort Myers, our dedicated resource page provides an in-depth overview of what patients can expect.

Our Protocol and Clinical Team

Our ketamine infusion protocol for chronic pain differs in some respects from the protocol used for psychiatric indications like treatment-resistant depression. Pain infusions often involve longer sessions and, for some conditions like CRPS, may be administered over a multi-day inpatient or intensive outpatient format depending on the severity and duration of the condition. Our team tailors the protocol to each patient after reviewing their history with our anesthesia-trained and psychiatry-trained providers. Stephen Durand, CRNA, brings specific anesthesia expertise to our ketamine program that allows us to manage infusions with a level of pharmacological precision that not every ketamine clinic in Southwest Florida can offer.

One barrier we encounter frequently among chronic pain patients is the weight of prior treatment failure. Many patients who contact our Fort Myers office have spent years or even decades seeking relief through multiple specialists, medications, procedures, and therapies — and have understandably arrived at our door exhausted and skeptical. We meet that skepticism with honesty rather than optimism: we tell patients what the evidence supports, what we have seen in our own clinical experience, and where uncertainty remains. We do not make promises about outcomes. What we do promise is that we will take your history seriously, evaluate your candidacy carefully, and offer our clinical judgment about whether ketamine therapy is likely to be beneficial for your specific condition. Discuss your full pain history with our team — that conversation is where good clinical decisions begin.

A second barrier is the financial and logistical reality of intensive treatment. Ketamine therapy for chronic pain is not covered by most commercial insurance plans, and the cost of a multi-infusion series can be significant. We offer transparent pricing and work with patients to structure payment options where possible. We also emphasize that the cost calculation needs to account for what ongoing undertreated pain costs — in lost work capacity, in reliance on opioids or other pain medications with their own risks and side effects, and in quality of life. For many of our patients, the functional improvement achieved through ketamine therapy represents a return on investment that conventional cost comparisons do not capture. We also complement ketamine therapy at Dura Medical with our medication management program, which can support neurological recovery and overall wellness as part of a comprehensive pain management plan.

Frequently Asked Questions

Is ketamine therapy for chronic pain FDA-approved?

No. The use of ketamine for chronic pain conditions is off-label — it is not FDA-approved for this indication. However, off-label use is legal, common in medicine, and supported by a significant body of clinical research. Our team conducts a thorough informed consent process so every patient fully understands the clinical evidence, the risks, and the alternatives before proceeding.

What chronic pain conditions does Dura Medical treat with ketamine?

We have clinical experience treating complex regional pain syndrome (CRPS), fibromyalgia, neuropathic pain, and migraine with ketamine infusions. We evaluate each patient individually before making any recommendation, as not every pain condition responds equally to this treatment approach. You can also review our ketamine FAQs for answers to the most common questions about ketamine therapy at our clinic.

How many ketamine infusions are needed for chronic pain?

The number of infusions varies based on the condition and the patient’s response. Some patients receive an initial series of four to six infusions over one to two weeks. CRPS patients may require longer or more intensive courses. Our team will give you an honest estimate based on your specific diagnosis and history after the initial evaluation.

Will ketamine therapy replace my other pain medications?

Not necessarily, and we do not recommend making any changes to your medication regimen without coordinating with our team and your prescribing providers. Some patients are able to reduce reliance on opioids or other analgesics following ketamine treatment, but this depends on individual response. Discuss any medication changes with your provider before making adjustments.

Does Dura Medical accept insurance for ketamine pain treatment?

Insurance coverage for ketamine in chronic pain is limited with most carriers. We provide transparent pricing and will discuss self-pay options during your consultation. For patients whose pain conditions have a psychiatric component — depression or PTSD co-occurring with chronic pain — coverage considerations may be different. Visit our accepted insurances page or contact our billing team for guidance specific to your situation.

Key Takeaways

  • Ketamine for chronic pain is an off-label application supported by clinical research, particularly for conditions involving central sensitization such as CRPS and fibromyalgia.
  • Ketamine blocks NMDA receptors to interrupt the neurological amplification process driving many chronic pain conditions.
  • Dura Medical’s team includes Stephen Durand, CRNA, providing anesthesia-level expertise in ketamine infusion management.
  • Protocol design for chronic pain differs from psychiatric applications and is customized to each patient’s condition and history.
  • Results vary by individual; discuss your full pain history with our team before considering any new treatment.

Conclusion

Chronic pain that has not responded to conventional treatment deserves a clinical team willing to look beyond conventional solutions. At Dura Medical in Fort Myers, our team has built the clinical depth to evaluate your pain condition carefully and to offer ketamine therapy where the evidence and your individual profile suggest it may help. We do not offer false hope — but we do offer a thorough evaluation, honest clinical judgment, and access to a treatment that has meaningfully changed the experience of pain for many of our patients across Southwest Florida. Contact our Fort Myers office or visit duramedical.us to begin the conversation.

References

American Academy of Pain Medicine. The Use of Opioids for the Treatment of Chronic Pain. https://painmed.org/

National Institute of Neurological Disorders and Stroke. Complex Regional Pain Syndrome Fact Sheet. https://www.ninds.nih.gov/health-information/disorders/complex-regional-pain-syndrome

Cleveland Clinic. Ketamine Infusion Therapy. https://my.clevelandclinic.org/health/treatments/24058-ketamine-infusion-therapy

Bell RF, Kalso EA. Ketamine for pain management. PAIN Reports. 2018;3(5):e674. doi: 10.1097/PR9.0000000000000674. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181464/

About Dura Medical Team

At Dura Medical, our team is founded by Stephen Durand, CRNA, and led by Medical Director Dr. Richard Capiola, who holds triple board certification in general psychiatry, addiction psychiatry, and forensic psychiatry and brings over 30 years of psychiatric experience to the treatment of patients with treatment-resistant anxiety, depression, and related conditions. We offer ketamine infusion therapy, TMS, and medication management at our Naples and Fort Myers locations, accepting most major insurance carriers and maintaining VA contracts that cover TMS through the Community Care Network for eligible veterans at no cost. Our team’s depth of psychiatric and anesthesia expertise allows us to address the full biological complexity driving each patient’s condition — recognizing when standard treatments are insufficient and applying advanced interventions with precision and care.

Medical Disclaimer

This content is provided by Dura Medical for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Ketamine for chronic pain is an off-label use of an approved medication. Only a qualified medical provider can determine whether ketamine therapy is appropriate for your specific situation. Results vary by individual, and no outcomes are guaranteed. Please discuss all treatment options with your provider before making any decisions about your care.

Family holding hands and walking through shallow ocean water at sunset.

Request An Appointment